These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 33993888

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Keeping up to date: a current review of wearable cardioverter defibrillator use.
    Ashraf S, Ilyas S, Siddiqui F, Ando T, Shokr M, Panaich S, Briasoulis A, Afonso L, Khan M.
    Acta Cardiol; 2020 Dec; 75(8):695-704. PubMed ID: 31687917
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.
    Daimee UA, Vermilye K, Moss AJ, Goldenberg I, Klein HU, McNitt S, Zareba W, Kutyifa V.
    Heart Rhythm; 2018 Sep; 15(9):1379-1386. PubMed ID: 29678779
    [Abstract] [Full Text] [Related]

  • 26. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T, Garisto JD, Salow A, Glad JM, Szymkiewicz S, Saltzman HE, Kutalek SP, Carrillo RG.
    Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
    [Abstract] [Full Text] [Related]

  • 27. [Patients with a wearable cardioverter-defibrillator (WCD) : Prescription, function and rehabilitation support].
    Schlitt A, Guha M, Noutsias M, Klein HH, Klein HU.
    Herz; 2019 Aug; 44(5):379-389. PubMed ID: 29234842
    [Abstract] [Full Text] [Related]

  • 28. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland.
    Kovacs B, Reek S, Saguner AM, Krasniqi N, Eriksson U, Duru F.
    Swiss Med Wkly; 2019 Nov 04; 149():w20136. PubMed ID: 31707723
    [Abstract] [Full Text] [Related]

  • 29. Study of the wearable cardioverter defibrillator in advanced heart-failure patients (SWIFT).
    Barsheshet A, Kutyifa V, Vamvouris T, Moss AJ, Biton Y, Chen L, Storozynsky E, Wan C, Szymkiewicz SJ, Goldenberg I.
    J Cardiovasc Electrophysiol; 2017 Jul 04; 28(7):778-784. PubMed ID: 28429542
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective.
    Botto GL, Mantovani LG, Cortesi PA, De Ponti R, D'Onofrio A, Biffi M, Capucci A, Casu G, Notarstefano P, Scaglione M, Zanotto G, Boriani G, Italian Association of Arrhythmology and Cardiac Pacing (AIAC).
    Int J Cardiol; 2022 Jun 01; 356():12-18. PubMed ID: 35395289
    [Abstract] [Full Text] [Related]

  • 34. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
    Goldenberg I, Erath JW, Russo AM, Burch AE, Assmus B, Bonderman D, McNitt S, Kutyifa V.
    Heart Rhythm; 2021 Mar 01; 18(3):404-410. PubMed ID: 33248269
    [Abstract] [Full Text] [Related]

  • 35. First human safety and effectiveness study of defibrillation with a novel patch wearable cardioverter-defibrillator.
    Chovanec M, Petrů J, Hála P, Kralovec S, Thakkar AB, Mathews K, Dinger M, Ullery S, Eapen ZJ, Kumar UN, Neužil P.
    Europace; 2024 Jul 02; 26(7):. PubMed ID: 39001864
    [Abstract] [Full Text] [Related]

  • 36. Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry.
    Veltmann C, Winter S, Duncker D, Jungbauer CG, Wäßnig NK, Geller JC, Erath JW, Goeing O, Perings C, Ulbrich M, Roser M, Husser D, Gansera LS, Soezener K, Malur FM, Block M, Fetsch T, Kutyifa V, Klein HU.
    Clin Res Cardiol; 2021 Jan 02; 110(1):102-113. PubMed ID: 32377784
    [Abstract] [Full Text] [Related]

  • 37. [The Wearable Cardioverter Defibrillator (WCD) for the prevention of sudden cardiac death -- a single center experience].
    Reek S, Meltendorf U, Geller JC, Wollbrück A, Grund S, Klein HU.
    Z Kardiol; 2002 Dec 02; 91(12):1044-52. PubMed ID: 12490994
    [Abstract] [Full Text] [Related]

  • 38. Wearable Cardioverter-Defibrillators following Cardiac Surgery-A Single-Center Experience.
    Heimeshoff J, Merz C, Ricklefs M, Kirchhoff F, Haverich A, Bara C, Kühn C.
    Thorac Cardiovasc Surg; 2019 Mar 02; 67(2):92-97. PubMed ID: 29925094
    [Abstract] [Full Text] [Related]

  • 39. Use of the Wearable Cardioverter Defibrillator in High-Risk Populations.
    Lamichhane M, Safadi A, Surapaneni P, Salehi N, Thakur RK.
    Curr Cardiol Rep; 2016 Aug 02; 18(8):78. PubMed ID: 27319008
    [Abstract] [Full Text] [Related]

  • 40. Real-world experience with the wearable cardioverter defibrillator: clinical effectiveness and wear-time adherence in patients at high risk for sudden cardiac death.
    Weth C, Abuazab H, Ewen S, Ukena C, Böhm M, Custodis F.
    Herzschrittmacherther Elektrophysiol; 2022 Mar 02; 33(1):55-62. PubMed ID: 34694459
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.